What are Calcitonin receptor agonist drugs?

Calcitonin receptor agonist drugs are pharmacologic agents that share a common mechanism (typically targeting Calcitonin receptor). 3 are currently marketed, with 1 more in clinical development.

What are the marketed Calcitonin receptor agonist drugs?

Marketed Calcitonin receptor agonist drugs include Intranasal calcitonin, Salmon Calcitonin, Miacalcin Calcitonin Salmon Nasal Spray.

Calcitonin receptor agonist

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

3 marketed 1 in Phase 3

This page covers all Calcitonin receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Calcitonin receptor.

Targets

Calcitonin receptor

Marketed (3)

Intranasal calcitonin · Université de Montréal · Endocrinology / Bone metabolism
Intranasal calcitonin is a peptide hormone that binds to calcitonin receptors on osteoclasts to inhibit bone resorption and increase bone mineral density.
Salmon Calcitonin · Eli Lilly and Company · Endocrinology / Bone metabolism
Salmon calcitonin is a peptide hormone that binds to calcitonin receptors on osteoclasts to inhibit bone resorption and lower serum calcium levels.
Miacalcin Calcitonin Salmon Nasal Spray · University of Missouri-Columbia · Endocrinology / Bone Metabolism
Calcitonin salmon is a peptide hormone that binds to calcitonin receptors on osteoclasts to inhibit bone resorption and increase urinary calcium excretion.

Phase 3 pipeline (1)

Oral Calcitonin Tablets · Tarsa Therapeutics, Inc. · Bone metabolism / Osteoporosis
Oral calcitonin activates calcitonin receptors on osteoclasts to inhibit bone resorption and reduce bone loss.

Patent intelligence

calcitonin receptor agonist patent landscape — aggregated cliff calendar, attackable patents, originator estates